Younan, H., Zhang, S., Monroy, M., Almusarhed, M., Julve, M., Roy, D., Toghey, S., Ahmed, Z., Slater, S., Altharwane, S., Giorgiou, A., Ghosh, S., Gennatas, S., Karapanagiotou, E., Montes, A., Pintus, E., Spicer, J., Shah, R., Ahmed, S., Newsom-Davis, T., Mohammed, W., Power, D., Evans, J., Hatcher, O., Lakhani, A., Samani, A., & Josephs, D. (n.d.). clinical predictors of long-term efficacy of first-line pembrolizumab monotherapy in non-small cell lung cancer (NSCLC): an interim analysis of real-world data. Lung cancer, 165, S32–. http://access.bl.uk/ark:/81055/vdc_100150603547.0x000037